TORONTO, July 24, 2024 /CNW/ - MyChoice, a Toronto-based Insurtech company, has released an insurance assistant that allows users in the US and Canada to receive real-time life insurance quotes while ...
Myriad Genetics, Inc. MYGN recently submitted a supplementary premarket approval (sPMA) application to the FDA for its myChoice CDx test. This will enable the identification of women suffering from ...
The filing comes as recent upgrades to NCCN guidelines expand the role of testing in the treatment of ovarian cancer. Myriad Genetics this week submitted the first part of its application to the FDA ...
“Nationally, the total amount of life insurance coverage has increased, but much of that coverage was locked in years ago" ...
Leading player in the molecular diagnostics and personalized medicine space, Myriad Genetics Inc.MYGN, announced that its myChoice homologous recombination deficiencies (HRD) test will effectively ...
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that the U.S. Food and Drug Administration ...
WEST DES MOINES, Iowa, Sept. 23, 2020 /PRNewswire/ -- A series of special reports released this month by Businessolver®, a leader in SaaS-based benefits technology and services, expose how COVID-19 ...
The University of Chicago’s myCHOICE (Chicago Options in Career Empowerment) program, which launched in 2014 to broaden experiences in scientific training and career exploration for PhD students, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results